Insmed (INSM) Operating Expenses (2010 - 2026)

Insmed's Operating Expenses history runs 17 years deep, the most recent figure standing at $459.3 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 34.7% year-over-year to $459.3 million; the TTM figure through Mar 2026 stood at $2.0 billion (up 44.76% YoY), while the FY2025 annual figure was $1.9 billion, up 49.22% from the prior year.
• Operating Expenses was $459.3 million for Q1 2026 at Insmed, down from $583.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $583.6 million in Q4 2025 to a low of $142.9 million in Q1 2022.
• Historically, Operating Expenses has averaged $310.1 million across 5 years, with a median of $306.9 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses jumped 103.7% in 2023, then grew 3.58% in 2024.
• A 5-year view of Operating Expenses shows it stood at $210.8 million in 2022, then advanced by 24.29% to $262.0 million in 2023, then advanced by 27.82% to $334.9 million in 2024, then jumped by 74.28% to $583.6 million in 2025, then declined by 21.3% to $459.3 million in 2026.
• The last three Operating Expenses figures came in at $459.3 million (Q1 2026), $583.6 million (Q4 2025), and $508.3 million (Q3 2025), per Business Quant data.